Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

VARA Consensus

Merck KGaA, Darmstadt, Germany, is covered by 24 sell-side analysts who make financial projections on the company. Merck KGaA, Darmstadt, Germany, authorizes VARA Research to compile an accurate and up to date consensus of these various projections that are published once per quarter. Merck KGaA, Darmstadt, Germany, does not endorse these estimates and the figures are gathered independently by VARA Research.
Please click here to download the latest VARA Consensus.
The most recent analyst consensus provided by VARA Research is listed below.
VARA Consensus Expectations for Q1 2017 (as of May 2017)
in € MillionHighMeanLow
Net sales


EBITDA (pre one-time items) 1)1,240.01,205.31,141.5
EPS (pre one-time items) 1)€ 1.78€ 1.72€ 1.68
VARA Consensus Expectations for Full Year 2017 (as of May 2017)
in € MillionHighMeanLow
Net sales15,904.415,684.015,549.0
EBITDA (pre one-time items) 1)4,634.54,562.64,513.0
EPS (pre one-time items) 1)€ 6.61€ 6.43€ 6.27
  1. For reconciliation details on EBITDA (pre one-time items) and EPS (pre one-time items) see the quarterly financial statement of Merck KGaA, Darmstadt, Germany.
Consensus on recently published Share Price Targets and Recommendations (as of May 2017)
Target share price in €117.30102.75103.50108.88
Share bar chart

Vara Research

Disclaimer: The Vara Research documents have been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.
The details otherwise specified above are no more than the results of analyses, reports, studies, recommendations and assessments provided by third parties, particularly by analysts. The details are not based on research conducted by Merck KGaA, Darmstadt, Germany itself. Merck KGaA, Darmstadt, Germany has merely collected this data and information and would like to bring it to your attention, though without making its own recommendations or assessments. Note, in particular, that the above-mentioned details are not recommendations or offers to purchase or sell the company's shares or other financial instruments. Merck KGaA, Darmstadt, Germany does not necessarily share the conclusions, recommendations or views expressed by the analysts providing the details and does not confirm the correctness or the suitability of the above-mentioned details or of the underlying information. Merck KGaA, Darmstadt, Germany accepts no liability for the selection, quality, completeness, up-to-dateness or correctness of the assessments and recommendations specified therein. Merck KGaA, Darmstadt, Germany accepts no liability for damage arising from the information provided on this internet site.


Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.
Open the following links in a RSS Reader of your choice